{
  "company_name": "Spruce Biosciences",
  "overview": "Spruce Biosciences is a biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders, including polycystic ovary syndrome (PCOS). They are running clinical trials for a drug called tildacerfont aimed at treating PCOS.",
  "location": "San Francisco, California, United States",
  "website": "https://www.sprucebiosciences.com",
  "therapeutic_areas": [
    "endocrinology",
    "women's health"
  ],
  "clinical_trials": {
    "phase_2_failed": [],
    "phase_3_failed": [],
    "dormant_assets": [
      {
        "asset_name": "tildacerfont",
        "indication": "PCOS",
        "status": "dormant",
        "notes": "Limited information on trial outcomes; potential for reevaluation"
      }
    ]
  },
  "drug_assets": [
    {
      "name": "tildacerfont",
      "modality": "small molecule",
      "indication": "PCOS",
      "development_stage": "phase 2",
      "target": null
    }
  ],
  "decision_makers": [
    {
      "name": "Percival Barretto-Ko",
      "role": "Spruce Biosciences",
      "linkedin_url": "https://www.linkedin.com/in/pbarrettoko",
      "email": null,
      "source": "serpapi"
    },
    {
      "name": "Kirk Ways",
      "role": "Spruce Biosciences",
      "linkedin_url": "https://www.linkedin.com/in/kirk-ways-b436a67",
      "email": null,
      "source": "serpapi"
    },
    {
      "name": "Mary Romeo",
      "role": "SPARK at Stanford",
      "linkedin_url": "https://www.linkedin.com/in/marydromeo",
      "email": null,
      "source": "serpapi"
    },
    {
      "name": "Alexis Howerton, Ph.D.",
      "role": "Founder/CEO",
      "linkedin_url": "https://www.linkedin.com/in/alexis-howerton-ph-d-7839076b",
      "email": null,
      "source": "serpapi"
    },
    {
      "name": "Mike Grey",
      "role": "Sorriso Pharmaceuticals",
      "linkedin_url": "https://www.linkedin.com/in/mikegrey",
      "email": null,
      "source": "serpapi"
    }
  ],
  "investors": [],
  "fit_score_for_convexia": 70,
  "reason_for_fit_score": "Spruce Biosciences has a clear focus on endocrine disorders, including PCOS, with a drug in clinical trials. Despite the lack of detailed outcomes, the scientific rationale and therapeutic focus align with Convexia's interest in rescuing failed or dormant assets.",
  "data_sources_used": [
    "https://www.nbcnews.com/health/womens-health/pcos-diagnosis-treatment-difficult-women-rcna142430"
  ],
  "last_updated": "2025-11-17 22:57:39.479796"
}